Effect of Ni doping on the acetone vapor sensing performance of ZnO nanofibers

Autor: Prabhu, Niranjan.N., Shivamurthy, B., Anandhan, S., Rajendra, B.V., Kulkarni, Suresh.D.

Publikováno v: In Ceramics International November 2024

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A Facile Strategy to Achieve High Piezoelectric Performance in Electrospun Poly(Vinylidene Fluoride) Non-woven Nanofabrics.

Autor: Khalifa, Mohammed, Kumar, Manish, Subramanian, Gokul, Anandhan, S.

Publikováno v: Transactions on Electrical & Electronic Materials; Apr2024, Vol. 25 Issue 2, p201-209, 9p

An electroactive β-phase polyvinylidene fluoride as gel polymer electrolyte for magnesium–ion battery application

Autor: Singh, Rupali, Janakiraman, S., Khalifa, Mohammed, Anandhan, S., Ghosh, Sudipto, Venimadhav, A., Biswas, K.

Publikováno v: In Journal of Electroanalytical Chemistry 10 October 2019 851

TSG-6+ cancer-associated fibroblasts modulate myeloid cell responses and impair anti-tumor response to immune checkpoint therapy in pancreatic cancer.

Autor: Anandhan S; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; The James P. Allison Institute, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Herbrich S; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; The James P. Allison Institute, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Goswami S; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; The James P. Allison Institute, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Guan B; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; The James P. Allison Institute, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Chen Y; Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Macaluso MD; Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jindal S; Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Natarajan SM; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Andrewes SW; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; The James P. Allison Institute, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Xiong L; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; The James P. Allison Institute, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nagarajan A; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; The James P. Allison Institute, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Basu S; Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tang DN; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; The James P. Allison Institute, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Liu J; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; The James P. Allison Institute, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Min J; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Sheikh Ahmed Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Maitra A; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Sheikh Ahmed Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Sharma P; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. PadSharma@mdanderson.org.; The James P. Allison Institute, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. PadSharma@mdanderson.org.; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. PadSharma@mdanderson.org.; Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. PadSharma@mdanderson.org.

Publikováno v: Nature communications [Nat Commun] 2024 Jul 10; Vol. 15 (1), pp. 5291. Date of Electronic Publication: 2024 Jul 10.